De Luca Maurizio, Belluzzi Amanda, Salminen Paulina, Bueter Marco, Pujol-Rafols Juan, Sakran Nasser, Stier Christine, Taskin Halit Eren, Chiappetta Sonja, Carrano Francesco Maria, Di Lorenzo Nicola, Nienhuijs Simon, Puy Ramón Vilallonga, Stenberg Erik, Emous Marloes, Prager Gerhard, Himpens Jacques, Felsenreich Daniel Moritz, Iannelli Antonio, Parmar Chetan, Copaescu Catalin, Fried Martin, Ruiz-Úcar Elena, Cohen Ricardo V, Olmi Stefano, Angrisani Luigi, Ribeiro Rui, Bandini Giulia, Scoccimarro Daniele, Ragghianti Benedetta, Monami Matteo
Department of General, Emergency and Metabolic Surgery, Rovigo Hospital, 45100 Rovigo, Italy.
Department of Surgery, University of Turku, 20014 Turku, Finland.
J Clin Med. 2024 Aug 28;13(17):5106. doi: 10.3390/jcm13175106.
: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. : The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. : These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. : The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.
肥胖症的流行已经成为一个全球性的健康问题。制定关于所有可用手段(即医学、内镜和手术干预以及指导计划)的直接指南,对于为肥胖患者提供最佳的多模式治疗方法至关重要。国际肥胖与代谢疾病外科联合会欧洲分会(IFSO-EC)指定了一个专家小组来制定本指南。该小组提出了一系列临床问题(基于患者、干预措施、对照和结果的概念框架),这些问题已经投票通过。将应用GRADE方法来评估证据质量,并制定建议以尽量减少选择和信息偏倚。这种方法旨在提高建议的可靠性和有效性,促进对现有最佳证据的更多遵循。这些指南适用于体重指数(BMI)≥30kg/m²且适合进行代谢性减重手术(MBS)的成年患者。负责制定这些指南的专家小组由25名小组成员(92%为减重外科医生)和3名证据审查员组成,平均年龄为50.1±10.2岁。该小组关注了关于结构化生活方式干预、已批准的肥胖管理药物以及内镜减重手术与MBS联合使用的3个关键问题。肥胖作为一种慢性病的复杂性需要全面了解所有可用且可行的治疗选择。IFSO-EC协会深感迫切需要制定方法学上有效的指南,以全面介绍并提高对多模式方法中可能采用的手术和非手术治疗策略的认识。